Țară: Regatul Unit
Limbă: engleză
Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dimethyl fumarate
Almirall Ltd
N07XX09
Dimethyl fumarate
30mg
Gastro-resistant tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: ; GTIN: 8430308130413
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SKILARENCE 30 MG GASTRO-RESISTANT TABLETS dimethyl fumarate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Skilarence is and what it is used for 2. What you need to know before you take Skilarence 3. How to take Skilarence 4. Possible side effects 5. How to store Skilarence 6. Contents of the pack and other information 1. WHAT SKILARENCE IS AND WHAT IT IS USED FOR WHAT SKILARENCE IS Skilarence is a medicine that contains the active substance dimethyl fumarate. Dimethyl fumarate works on cells of the immune system (the body's natural defences). It changes the activity of the immune system and reduces the production of substances involved in causing psoriasis. WHAT SKILARENCE IS USED FOR Skilarence tablets are used to treat moderate to severe plaque psoriasis in adults. Psoriasis is a disease causing thickened, inflamed, red areas on the skin, often covered by silvery scales. Response to Skilarence can be generally seen as early as week 3 and improves over time. Experience with related products containing dimethyl fumarate shows treatment benefit for at least up to 24 months. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SKILARENCE DO NOT TAKE SKILARENCE - if you are allergic to dimethyl fumarate or any of the other ingredients of this medicine (listed in section 6) - if you have severe problems with your stomach or intestines - if you have severe liver or kidney problems - if you are pregnant or breast-feeding WARNINGS AND PRECAUTIONS Talk to your doctor Citiți documentul complet
OBJECT 1 SKILARENCE 30 MG GASTRO-RESISTANT TABLETS Summary of Product Characteristics Updated 22-Jun-2018 | Almirall Limited 1. Name of the medicinal product Skilarence 30 mg gastro-resistant tablets Skilarence 120 mg gastro-resistant tablets 2. Qualitative and quantitative composition Skilarence 30 mg Each gastro-resistant tablet contains 30 mg dimethyl fumarate. Skilarence 120 mg Each gastro-resistant tablet contains 120 mg dimethyl fumarate. Excipient with known effect Skilarence 30 mg Each gastro-resistant tablet contains 34.2 mg lactose (as monohydrate). Skilarence 120 mg Each gastro-resistant tablet contains 136.8 mg lactose (as monohydrate). For the full list of excipients, see section 6.1. 3. Pharmaceutical form Gastro-resistant tablet. Skilarence 30 mg White, film-coated, round, biconvex tablet with a diameter of approximately 6.8 mm. Skilarence 120 mg Blue, film-coated, round, biconvex tablet with a diameter of approximately 11.6 mm. 4. Clinical particulars 4.1 Therapeutic indications Skilarence is indicated for the treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy. 4.2 Posology and method of administration Skilarence is intended for use under the guidance and supervision of a physician experienced in the diagnosis and treatment of psoriasis. Posology To improve tolerability, it is recommended to begin treatment with a low initial dose with subsequent gradual increases. In the first week, Skilarence 30 mg is taken once daily (1 tablet in the evening). In the second week, Skilarence 30 mg is taken twice daily (1 tablet in the morning and 1 in the evening). In the third week, Skilarence 30 mg is taken three times daily (1 tablet in the morning, 1 at midday, and 1 in the evening). From the fourth week, treatment is switched to only 1 tablet of Skilarence 120 mg in the evening. This dose is then increased by 1 Skilarence 120 mg tablet per week at different times of day for the subsequent 5 weeks, as shown in the table below. The maximum daily dose allowed is 72 Citiți documentul complet